Antibodies.Com 3CTT.1, Anti-Podoplanin Antibody [LpMab-23]

The Antibodies.Com 3CTT.1 Anti-podoplanin antibody is a specialised research antibody developed for the detection and analysis of podoplanin (PDPN), a transmembrane glycoprotein widely investigated as a biological marker. The LpMab-23 clone provides targeted recognition of podoplanin, supporting precise laboratory-based protein identification and research workflows. It is intended for research use and supports laboratory investigations that require selective antibody-based detection.

Targeted Podoplanin Recognition

Designed to bind specifically to podoplanin, the LpMab-23 antibody enables researchers to investigate PDPN expression in relevant biological samples. Its target-specific binding makes it a valuable reagent where dependable identification and characterisation of podoplanin are required.

Key Research Benefits of the Antibodies.Com 3CTT.1 Anti-Podoplanin Antibody

• Anti-Podoplanin research antibody.
• LpMab-23 antibody clone.
• Targets podoplanin (PDPN).
• Supports selective protein detection and analysis.
• Designed for controlled laboratory research workflows.
• Suitable for investigating podoplanin expression.
• Supplied as a specialised research reagent.

Product Use Cases

The 3CTT.1 can support podoplanin-focused research across areas such as:

• Cancer and tumour biology research
• Podoplanin expression studies
• Biomarker identification and characterisation
• Cell and molecular biology research
• Protein detection and localisation studies
• Tissue-based laboratory investigations
• Experimental biomedical research